Evidence map›Paper›PMID 42703334›Full record

ArticleJournal of gastrointestinal oncology2026

Cuproplasia-associated LOXL2 cooperates with

Jin Wang, Wenzi Meng, Jiahui Zhu, Guangzhao Tao, Yujian Xia, Yao Li, Xin Zhao, Yunliang Wang

Abstract read
In one paragraph

Article in Journal of gastrointestinal oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jin Wang *Department of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Wenzi Meng *Department of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Jiahui ZhuDepartment of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Guangzhao TaoDepartment of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Yujian XiaDepartment of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Yao LiDepartment of Gastroenterology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Xin ZhaoDepartment of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Yunliang WangDepartment of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Gastric cancer (GC) remains a major cause of cancer-related mortality worldwide, and Methods: Transcriptomic and clinical data were analyzed to construct a risk model for Results: A five-gene cuproplasia-related signature showed strong predictive performance for Conclusions: Rather than serving merely as a prognostic biomarker, LOXL2 functions as a cuproplasia-associated effector that cooperates with

Indexed as

cuproplasiaFAK/Src signalingGastric cancer (GC)Helicobacter pylori (H. pylori)LOXL2

Identifiers

PMID42703334
PMCPMC13546562

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.